SCHEMBL26833541

SCHEMBL26833541

c1ccc2cc(-c3ccc4c(ccc5cc(N(c6ccc(-c7nccc8ccncc78)cc6)c6ccc(-c7nccc8ccncc78)cc6)ccc54)c3)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 1/20 0.42
▸ CYP19A1 P11511 1/20 0.42
▸ CYP11B1 P15538 1/20 0.42
▸ CYP11B2 P19099 1/20 0.42
▸ MAPK10 P53779 6/20 0.41
▸ MAPK9 P45984 3/20 0.41
▸ MAPK8 P45983 2/20 0.41
▸ HTR2B P41595 1/20 0.37
▸ HTR5A P47898 1/20 0.37
▸ PRKCZ Q05513 1/20 0.35
▸ TNF P01375 1/20 0.35
▸ TDO2 P48775 2/20 0.34
▸ PRKCI P41743 1/20 0.34
▸ CCNC P24863 1/20 0.34
▸ CDK8 P49336 1/20 0.34
▸ AKT1 P31749 1/20 0.34
▸ HIPK2 Q9H2X6 1/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ PIK3CD O00329 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26833540 0.92 CYP17A1 (0.41) CYP17A1CYP19A1CYP11B1CYP11B2MAPK10
SCHEMBL26833461 0.90 HTR2B (0.42) CYP17A1CYP19A1CYP11B1CYP11B2MAPK10
SCHEMBL26833626 0.87 HTR2B (0.44) CYP17A1CYP19A1CYP11B1CYP11B2MAPK10
SCHEMBL26833455 0.85 PRKCZ (0.50) CYP17A1CYP19A1CYP11B1CYP11B2MAPK10
SCHEMBL26833454 0.85 CYP17A1 (0.48) CYP17A1CYP19A1CYP11B1CYP11B2MAPK10
SCHEMBL26833649 0.85 CYP17A1 (0.41) CYP17A1CYP19A1CYP11B1CYP11B2MAPK10
SCHEMBL26833469 0.85 TNF (0.55) CYP17A1CYP19A1CYP11B1CYP11B2MAPK10
SCHEMBL26833571 0.85 HTR2B (0.40) CYP17A1CYP19A1CYP11B1CYP11B2MAPK10
SCHEMBL26833663 0.84 MAPK10 (0.43) CYP17A1CYP19A1CYP11B1CYP11B2MAPK10
SCHEMBL26833521 0.82 PDGFRB (0.48) CYP17A1CYP19A1CYP11B1CYP11B2MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 CYP17A1 560/4885CYP19A1 318/4885CYP11B1 968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback